Related Experiment Video
Updated: Aug 7, 2026
07:28
Auricular Point Acupressure Therapy: A Safe and Effective Treatment for Postsurgical Abortion Recovery
Published on: February 3, 2026
[Early pregnancy termination: what the generalist should know]
A P Lourenço1, C Reuse, D de Ziegler
1Endocrinologie gynécologique et médecine de la reproduction, Réseau romand de procréation assistée HUG, 1211 Genève. Ana.P.Lourenco@hcuge.ch
Revue Medicale Suisse
|June 17, 2006
Summary
Medical abortion, using mifepristone and misoprostol, is a common choice for early pregnancy termination. While generally safe, rare fatal infections can occur, requiring careful consideration of clinical characteristics and underlying causes.
Area of Science:
- Obstetrics and Gynecology
- Pharmacology
Context:
- Abortion is a common procedure requested by many women before 12 weeks of gestation.
- Medical abortion is a widely used method for early pregnancy termination in Switzerland.
Purpose:
- To review the legal aspects of abortion in Switzerland.
- To detail the methods, contraindications, and complications of medical abortion.
- To present and discuss rare fatal infection cases following medical abortion.
Summary:
- This review covers the legal framework for abortion in Switzerland and the primary methods for medical abortion, including mifepristone and misoprostol.
- It outlines contraindications and common complications associated with these methods.
- The abstract highlights recently reported rare but fatal cases of infection post-medical abortion, detailing their clinical features and exploring the pathophysiology.
Impact:
- Provides a comprehensive overview of medical abortion in the Swiss context.
- Raises awareness about rare but severe complications, such as fatal infections.
- Contributes to understanding the clinical presentation and potential mechanisms of infection following medical abortion.
Related Concept Videos
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:27Ovarian Cycle
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...